Who commented on Presenting Risk Information in Prescription Drug and Medical Device Promotion, the FDA Perspective; Draft Guidance for Industry?

Question

Accepted Answer

2 organizations filed 2 public comments on Presenting Risk Information in Prescription Drug and Medical Device Promotion, the FDA Perspective; Draft Guidance for Industry (FDA-2008-D-0253) on regulations.gov.

Presenting Risk Information in Prescription Drug and Medical Device Promotion, the FDA Perspective; Draft Guidance for Industry

Commenters (2)